COE Retention Strategies - JHF

May 6, 2026 to May 20, 2026

Participants will identify the benefits of sustained client engagement in substance use treatment and examine risk factors that contribute to disengagement at the individual, social, and systemic levels. They will also apply evidence-based care management strategies to prevent and respond to disengagement, with a focus on strengthening relationships, addressing social drivers of health, and supporting re-engagement.

Agenda:

  1. Introduction
  2. Background
    1. Definition of client engagement
    2. Treatment gap: 6.1M people with OUD in 2022; ~87% not receiving MOUD; low program completion rates
    3. Care manager's role: needs assessment, care planning, outreach, resource linkage, care transitions
  3. Benefits of Engagement
    1. Survival: MOUD retention reduces overdose mortality (59% reduction with methadone; 38% with buprenorphine)
    2. Improved life outcomes: abstinence, fewer ED visits, fewer arrests
    3. Reduced system costs: care coordination lowers unnecessary acute care
    4. Recovery capital: outreach, peer support, and wraparound services
    5. Discussion question: reflect on a client you helped stay engaged
  4. Recognizing the Risk of Disengagement
    1. Early warning signs: missed appointments, no response to outreach, housing instability, crisis escalation, hopelessness, insurance gaps
    2. Individual-level factors: age, motivation, co-occurring mental health conditions, internalized stigma
    3. Relational & social factors: weak therapeutic relationship, provider stigma, social isolation
    4. Systemic & structural factors: rigid requirements, fragmented care, limited MOUD access
    5. Ambivalence: visible behaviors (minimizing, deflecting, disappearing) vs. hidden drivers (mistrust, pessimism)
    6. Coercion: perceived coercion drives poor outcomes; respectful, autonomy-supportive approaches improve retention
    7. SDOH as disengagement drivers: housing, transportation, economic instability, justice involvement, isolation, food insecurity
    8. SDOH + stigma: structural, provider, and self-stigma compound each other
  5. Strategies to Prevent and Address Disengagement
    1. Addressing SDOH: screen at every contact, document barriers, connect to community resources, advocate, use flexible outreach
    2. Ongoing needs assessments & care plans: validated tools, individualized plans reflecting goals, barriers, and strengths
    3. Protective factors
    4. Proactive outreach: follow up on no-shows within 24–48 hours, use EHR flags, engage trusted supports
    5. Reengagement: act fast, nonjudgmental outreach, update care plan, ensure naloxone and safety planning
  6. Key Takeaways
    1. Disengagement is clinical, driven by distress, stigma, and social barriers
    2. The relationship determines the outcome, respect and autonomy matter
    3. Address SDOH, not just diagnosis, survival needs compete with care
    4. First 30 days are highest risk; proactive outreach is the primary strategy
    5. Screen continuously; care plans must stay current
    6. Resistance = ambivalence; respond with curiosity, not confrontation
  7. Latterman Family Health Center COE Presentation
    1. Foundation: Philosophy & Relationships
      1. Clients self-select into care; start with their goals and values
      2. Engagement is built through trust and human connection
      3. Prioritize relationship-building over compliance
      4. Meeting clients at their stage of change
    2. Access & Engagement Strategies
      1. Flexible, low-barrier care (texting, reminders, drop-in options)
      2. Meet clients where they are (clinic, home, community)
      3. Consistent outreach—even when clients are inconsistent
      4. Engagement goes beyond attendance
    3. Addressing Needs Holistically (SDOH)
      1. Identify and address transportation, housing, food needs early
      2. Integrate SDOH into care planning
      3. Use partnerships and on-site resources
      4. Adapt care (e.g., harm reduction, early MOUD access)
    4. Preventing & Responding to Disengagement
      1. Recognize early warning signs (missed visits, reduced communication)
      2. Respond quickly with proactive, multi-method outreach
      3. Maintain a non-judgmental, supportive approach
      4. Normalize disengagement and celebrate re-engagement
  8. Discussion

Target Audience

  • Nurse
  • Physician
  • Social Worker

Learning Objectives

• Identify the benefits of sustained client engagement in substance use treatment and the care manager's role in supporting it.
• Examine individual, social, and systemic risk factors associated with treatment and care management disengagement.
• Apply evidence-based care management strategies to prevent and respond to disengagement.

 

 

Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.25 ASWB
  • 1.25 Attendance
Course opens: 
05/20/2026
Course expires: 
06/20/2026
Event starts: 
05/06/2026 - 12:00pm EDT
Event ends: 
05/20/2026 - 1:30pm EDT

Participants will identify the benefits of sustained client engagement in substance use treatment and examine risk factors that contribute to disengagement at the individual, social, and systemic levels. They will also apply evidence-based care management strategies to prevent and respond to disengagement, with a focus on strengthening relationships, addressing social drivers of health, and supporting re-engagement.

Agenda:

  1. Introduction
  2. Background
    1. Definition of client engagement
    2. Treatment gap: 6.1M people with OUD in 2022; ~87% not receiving MOUD; low program completion rates
    3. Care manager's role: needs assessment, care planning, outreach, resource linkage, care transitions
  3. Benefits of Engagement
    1. Survival: MOUD retention reduces overdose mortality (59% reduction with methadone; 38% with buprenorphine)
    2. Improved life outcomes: abstinence, fewer ED visits, fewer arrests
    3. Reduced system costs: care coordination lowers unnecessary acute care
    4. Recovery capital: outreach, peer support, and wraparound services
    5. Discussion question: reflect on a client you helped stay engaged
  4. Recognizing the Risk of Disengagement
    1. Early warning signs: missed appointments, no response to outreach, housing instability, crisis escalation, hopelessness, insurance gaps
    2. Individual-level factors: age, motivation, co-occurring mental health conditions, internalized stigma
    3. Relational & social factors: weak therapeutic relationship, provider stigma, social isolation
    4. Systemic & structural factors: rigid requirements, fragmented care, limited MOUD access
    5. Ambivalence: visible behaviors (minimizing, deflecting, disappearing) vs. hidden drivers (mistrust, pessimism)
    6. Coercion: perceived coercion drives poor outcomes; respectful, autonomy-supportive approaches improve retention
    7. SDOH as disengagement drivers: housing, transportation, economic instability, justice involvement, isolation, food insecurity
    8. SDOH + stigma: structural, provider, and self-stigma compound each other
  5. Strategies to Prevent and Address Disengagement
    1. Addressing SDOH: screen at every contact, document barriers, connect to community resources, advocate, use flexible outreach
    2. Ongoing needs assessments & care plans: validated tools, individualized plans reflecting goals, barriers, and strengths
    3. Protective factors
    4. Proactive outreach: follow up on no-shows within 24–48 hours, use EHR flags, engage trusted supports
    5. Reengagement: act fast, nonjudgmental outreach, update care plan, ensure naloxone and safety planning
  6. Key Takeaways
    1. Disengagement is clinical, driven by distress, stigma, and social barriers
    2. The relationship determines the outcome, respect and autonomy matter
    3. Address SDOH, not just diagnosis, survival needs compete with care
    4. First 30 days are highest risk; proactive outreach is the primary strategy
    5. Screen continuously; care plans must stay current
    6. Resistance = ambivalence; respond with curiosity, not confrontation
  7. Latterman Family Health Center COE Presentation
    1. Foundation: Philosophy & Relationships
      1. Clients self-select into care; start with their goals and values
      2. Engagement is built through trust and human connection
      3. Prioritize relationship-building over compliance
      4. Meeting clients at their stage of change
    2. Access & Engagement Strategies
      1. Flexible, low-barrier care (texting, reminders, drop-in options)
      2. Meet clients where they are (clinic, home, community)
      3. Consistent outreach—even when clients are inconsistent
      4. Engagement goes beyond attendance
    3. Addressing Needs Holistically (SDOH)
      1. Identify and address transportation, housing, food needs early
      2. Integrate SDOH into care planning
      3. Use partnerships and on-site resources
      4. Adapt care (e.g., harm reduction, early MOUD access)
    4. Preventing & Responding to Disengagement
      1. Recognize early warning signs (missed visits, reduced communication)
      2. Respond quickly with proactive, multi-method outreach
      3. Maintain a non-judgmental, supportive approach
      4. Normalize disengagement and celebrate re-engagement
  8. Discussion

 

Zoom Meeting
Pittsburgh, PA
United States

Shiryl Barto, M.Ed., Associate Program Implementation Specialist

Georgie Scott, MPH, Associate Program Implementation Specialist

Heather Mikes, DO FAAHPM

Hannah Scears, MS

 

In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and The Jewish Healthcare Foundation. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
As a Jointly Accredited Organization, University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Pittsburgh maintains responsibility for this course. Social workers completing this course receive 1.25 continuing education credits.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.25 contact hours.

Social Work (ASWB)
The maximum number of hours awarded for this Continuing Social Work Education activity is 1.25 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.25 ASWB
  • 1.25 Attendance
Please login or register to take this course.